Scipher Medicine and Chemomab Therapeutics Merge to Advance AI-Powered Drug Development
Scipher Medicine (NASDAQ: SCPH) has entered into a definitive all-stock merger agreement to acquire Chemomab Therapeutics (CMMB), integrating Chemomab’s liver disease drug pipeline and securing a Nasdaq listing. The deal, ... Read More